Sinemia Announces $30 “Unlimited” Movie Ticket Service As MoviePass Attempts Last-Ditch Effort To Stay Afloat

As MoviePass continues its inevitable spiral down in the toilet bowl of business, its competitors seem to have learned from the company’s mistakes and are prospering. We’ve already covered multiple MoviePass competitors, including AMC and Alamo Drafthouse, who feel they have figured out the trick to the movie ticket subscription service game. However, now we have Sinemia to add to the list, who just announced a major change to its service.

READ MORE: MoviePass Board Member Quits In Blaze Of Glory As Company Offers New Contest For A One Year Subscription

According to Variety, Sinemia has announced a new $30-per-month plan that would offer “unlimited” ticket purchasing for subscribers. While not truly unlimited, it basically works out to be exactly what MoviePass offered at $10-per-month, but with a higher price tag and the ability to buy tickets in advance from an app.

The details are simple: subscribers can watch one 2D movie per day using the service and only pay $30 per month. In addition to that plan, there will be tiered plans for those not wanting “unlimited” as well as plans that include 3D showings and family members.

Rifat Oguz, Sinemia CEO, said, “While most of our plans are focused on the modern moviegoer who sees one, two, or three movies each month, we want to serve every type of movie lover and that includes frequent moviegoers looking for an unlimited tickets option.”

He continues, saying Sinemia has spent several years testing the “unlimited” model and is “confident this is the right price to sustainably offer such a plan.”

READ MORE: Survey Suggests That ‘MoviePass’ Could Lose Almost 50% Of Its Subscribers Due To Recent Changes

As for the granddaddy of all this movie ticket subscription service mayhem, MoviePass is on life support and has one more shot at staying alive. According to Deadline, Helios & Matheson (the MoviePass parent company) has submitted a regulatory filing explaining its plan to raise the stock price of the company from $0.02 to $1 by December 18, when the stock will be delisted by NASDAQ.

In a move that has worked for the company previously (granted it was during the time when MoviePass was thriving), Helios & Matheson will attempt a reverse stock split, which is a way of consolidating shares and artificially increasing the stock price. While previously, the company has been far from doom and gloom, the filing that was submitted earlier paints a very bleak picture for Helios & Matheson’s (and subsequently Moviepass’) future.

READ MORE: MoviePass Has Lied, Misled, Cheated, & Failed Customers Repeatedly And F*ck It, I’m Out

“If the Company is unable to maintain its Nasdaq listing, its access to capital will become further limited and it may not have sufficient capital to enable MoviePass to continue its operations or become cash flow positive or profitable,” Helios & Mathewson said in a regulatory filing. “Therefore, the Board has concluded that the potential harm to the Company and its stockholders resulting from a Nasdaq delisting outweighs the potential harm to the Company and its stockholders from another significant reverse stock split.”

Again, as we’ve said time, and time again, MoviePass has one foot in the grave and is praying for a miracle. But honestly, it sounds like too little, too late.